866-997-4948(US-Canada Toll Free)

EMEA (Europe,Middle East and Africa) Immuno-oncology Drugs Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 126 Pages

In this report, the EMEA Immuno-oncology Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Immuno-oncology Drugs for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Immuno-oncology Drugs market competition by top manufacturers/players, with Immuno-oncology Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Pharmacies
Online Pharmacies

Table of Contents

EMEA (Europe, Middle East and Africa) Immuno-oncology Drugs Market Report 2018
1 Immuno-oncology Drugs Overview
1.1 Product Overview and Scope of Immuno-oncology Drugs
1.2 Classification of Immuno-oncology Drugs
1.2.1 EMEA Immuno-oncology Drugs Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Immuno-oncology Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Monoclonal Antibodies
1.2.5 Cytokine-Based Immunotherapy
1.2.6 Cancer Vaccines
1.2.7 CAR-T Cell Therapy
1.3 EMEA Immuno-oncology Drugs Market by Application/End Users
1.3.1 EMEA Immuno-oncology Drugs Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Online Pharmacies
1.4 EMEA Immuno-oncology Drugs Market by Region
1.4.1 EMEA Immuno-oncology Drugs Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Immuno-oncology Drugs (2013-2025)
1.5.1 EMEA Immuno-oncology Drugs Sales and Growth Rate (2013-2025)
1.5.2 EMEA Immuno-oncology Drugs Revenue and Growth Rate (2013-2025)

2 EMEA Immuno-oncology Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Immuno-oncology Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Immuno-oncology Drugs Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Immuno-oncology Drugs Revenue and Share by Players (2013-2018)
2.1.3 EMEA Immuno-oncology Drugs Sale Price by Players (2013-2018)
2.2 EMEA Immuno-oncology Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Immuno-oncology Drugs Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Immuno-oncology Drugs Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Immuno-oncology Drugs Sale Price by Type (2013-2018)
2.3 EMEA Immuno-oncology Drugs (Volume) by Application
2.4 EMEA Immuno-oncology Drugs (Volume and Value) by Region
2.4.1 EMEA Immuno-oncology Drugs Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Immuno-oncology Drugs Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Immuno-oncology Drugs Sales Price by Region (2013-2018)

3 Europe Immuno-oncology Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Immuno-oncology Drugs Sales and Value (2013-2018)
3.1.1 Europe Immuno-oncology Drugs Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
3.2 Europe Immuno-oncology Drugs Sales and Market Share by Type
3.3 Europe Immuno-oncology Drugs Sales and Market Share by Application
3.4 Europe Immuno-oncology Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Immuno-oncology Drugs Sales Volume by Countries (2013-2018)
3.4.2 Europe Immuno-oncology Drugs Revenue by Countries (2013-2018)
3.4.3 Germany Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.4.4 France Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.4.5 UK Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.4.6 Russia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.4.7 Italy Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
3.4.8 Benelux Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

4 Middle East Immuno-oncology Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Immuno-oncology Drugs Sales and Value (2013-2018)
4.1.1 Middle East Immuno-oncology Drugs Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
4.2 Middle East Immuno-oncology Drugs Sales and Market Share by Type
4.3 Middle East Immuno-oncology Drugs Sales and Market Share by Application
4.4 Middle East Immuno-oncology Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Immuno-oncology Drugs Sales Volume by Countries (2013-2018)
4.4.2 Middle East Immuno-oncology Drugs Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
4.4.4 Israel Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
4.4.5 UAE Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
4.4.6 Iran Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

5 Africa Immuno-oncology Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Immuno-oncology Drugs Sales and Value (2013-2018)
5.1.1 Africa Immuno-oncology Drugs Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
5.2 Africa Immuno-oncology Drugs Sales and Market Share by Type
5.3 Africa Immuno-oncology Drugs Sales and Market Share by Application
5.4 Africa Immuno-oncology Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Immuno-oncology Drugs Sales Volume by Countries (2013-2018)
5.4.2 Africa Immuno-oncology Drugs Revenue by Countries (2013-2018)
5.4.3 South Africa Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.4.5 Egypt Immuno-oncology Drugs Sales and Growth Rate (2013-2018)
5.4.6 Algeria Immuno-oncology Drugs Sales and Growth Rate (2013-2018)

6 EMEA Immuno-oncology Drugs Manufacturers/Players Profiles and Sales Data
6.1 Amgen, Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Immuno-oncology Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca, Plc
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Immuno-oncology Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Immuno-oncology Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Celgene Corporation
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Immuno-oncology Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly and Company
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Immuno-oncology Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Merck & Co.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Immuno-oncology Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Hoffmann-La Roche AG
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Immuno-oncology Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Immuno-oncology Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Novartis International AG
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Immuno-oncology Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 AbbVie, Inc.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Immuno-oncology Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Pfizer Inc.
6.12 Sanofi S.A.
6.13 EMD Serono, Inc.
6.14 Gilead Sciences Inc.
6.15 Prometheus Therapeutics & Diagnostics
6.16 Aduro BioTech
6.17 Galena Biopharma
6.18 Bavarian Nordic
6.19 Celldex Therapeutics
6.20 ImmunoCellular Therapeutics
6.21 Incyte

7 Immuno-oncology Drugs Manufacturing Cost Analysis
7.1 Immuno-oncology Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immuno-oncology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Immuno-oncology Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immuno-oncology Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Immuno-oncology Drugs Market Forecast (2018-2025)
11.1 EMEA Immuno-oncology Drugs Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Immuno-oncology Drugs Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Immuno-oncology Drugs Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Immuno-oncology Drugs Price and Trend Forecast (2018-2025)
11.2 EMEA Immuno-oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Immuno-oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Immuno-oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Immuno-oncology Drugs Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Immuno-oncology Drugs Sales Forecast by Type (2018-2025)
11.7 EMEA Immuno-oncology Drugs Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Immuno-oncology Drugs
Figure EMEA Immuno-oncology Drugs Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Immuno-oncology Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Immune Checkpoint Inhibitors Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Cytokine-Based Immunotherapy Product Picture
Figure Cancer Vaccines Product Picture
Figure CAR-T Cell Therapy Product Picture
Figure EMEA Immuno-oncology Drugs Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Immuno-oncology Drugs by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure EMEA Immuno-oncology Drugs Market Size (Million USD) by Region (2013-2025)
Figure Europe Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Immuno-oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Immuno-oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Immuno-oncology Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Immuno-oncology Drugs Sales Volume and Growth Rate (2013-2025)
Figure EMEA Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Immuno-oncology Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Immuno-oncology Drugs Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Immuno-oncology Drugs Sales Share by Players (2013-2018)
Figure 2017 Immuno-oncology Drugs Sales Share by Players
Figure 2017 Immuno-oncology Drugs Sales Share by Players
Figure EMEA Immuno-oncology Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Immuno-oncology Drugs Revenue (Million USD) by Players (2013-2018)
Table EMEA Immuno-oncology Drugs Revenue Share by Players (2013-2018)
Table 2017 EMEA Immuno-oncology Drugs Revenue Share by Players
Table 2017 EMEA Immuno-oncology Drugs Revenue Share by Players
Table EMEA Immuno-oncology Drugs Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Immuno-oncology Drugs Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Immuno-oncology Drugs Sales Share by Type (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Type (2013-2018)
Figure EMEA Immuno-oncology Drugs Sales Market Share by Type (2013-2018)
Table EMEA Immuno-oncology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Immuno-oncology Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Type in 2017
Table EMEA Immuno-oncology Drugs Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Immuno-oncology Drugs Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Immuno-oncology Drugs Sales Share by Application (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Application (2013-2018)
Figure EMEA Immuno-oncology Drugs Sales Market Share by Application in 2017
Table EMEA Immuno-oncology Drugs Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Immuno-oncology Drugs Sales Share by Region (2013-2018)
Figure Sales Market Share of Immuno-oncology Drugs by Region (2013-2018)
Figure EMEA Immuno-oncology Drugs Sales Market Share in 2017
Table EMEA Immuno-oncology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Immuno-oncology Drugs Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Immuno-oncology Drugs by Region (2013-2018)
Figure EMEA Immuno-oncology Drugs Revenue Market Share Regions in 2017
Table EMEA Immuno-oncology Drugs Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate (2013-2018)
Table Europe Immuno-oncology Drugs Sales (K Units) by Type (2013-2018)
Table Europe Immuno-oncology Drugs Market Share by Type (2013-2018)
Figure Europe Immuno-oncology Drugs Market Share by Type in 2017
Table Europe Immuno-oncology Drugs Sales (K Units) by Application (2013-2018)
Table Europe Immuno-oncology Drugs Market Share by Application (2013-2018)
Figure Europe Immuno-oncology Drugs Market Share by Application in 2017
Table Europe Immuno-oncology Drugs Sales (K Units) by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table Europe Immuno-oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Europe Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Germany Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure France Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure UK Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Immuno-oncology Drugs Sales (K Units) by Type (2013-2018)
Table Middle East Immuno-oncology Drugs Market Share by Type (2013-2018)
Figure Middle East Immuno-oncology Drugs Market Share by Type (2013-2018)
Table Middle East Immuno-oncology Drugs Sales (K Units) by Applications (2013-2018)
Table Middle East Immuno-oncology Drugs Market Share by Applications (2013-2018)
Figure Middle East Immuno-oncology Drugs Sales Market Share by Application in 2017
Table Middle East Immuno-oncology Drugs Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Immuno-oncology Drugs Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Immuno-oncology Drugs Sales Volume Market Share by Countries in 2017
Table Middle East Immuno-oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Immuno-oncology Drugs Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Immuno-oncology Drugs Sales (K Units) by Type (2013-2018)
Table Africa Immuno-oncology Drugs Sales Market Share by Type (2013-2018)
Figure Africa Immuno-oncology Drugs Sales Market Share by Type (2013-2018)
Figure Africa Immuno-oncology Drugs Sales Market Share by Type in 2017
Table Africa Immuno-oncology Drugs Sales (K Units) by Application (2013-2018)
Table Africa Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
Figure Africa Immuno-oncology Drugs Sales Market Share by Application (2013-2018)
Table Africa Immuno-oncology Drugs Sales Volume (K Units) by Countries (2013-2018)
Table Africa Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Immuno-oncology Drugs Sales Market Share by Countries (2013-2018)
Figure Africa Immuno-oncology Drugs Sales Market Share by Countries in 2017
Table Africa Immuno-oncology Drugs Revenue (Million USD) by Countries (2013-2018)
Table Africa Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Immuno-oncology Drugs Revenue Market Share by Countries (2013-2018)
Figure Africa Immuno-oncology Drugs Revenue Market Share by Countries in 2017
Figure South Africa Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Table Amgen, Inc Immuno-oncology Drugs Basic Information List
Table Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Amgen, Inc Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca, Plc Immuno-oncology Drugs Basic Information List
Table AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca, Plc Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Bristol-Myers Squibb Immuno-oncology Drugs Basic Information List
Table Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Bristol-Myers Squibb Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Celgene Corporation Immuno-oncology Drugs Basic Information List
Table Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Celgene Corporation Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly and Company Immuno-oncology Drugs Basic Information List
Table Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly and Company Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Merck & Co. Immuno-oncology Drugs Basic Information List
Table Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Merck & Co. Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Hoffmann-La Roche AG Immuno-oncology Drugs Basic Information List
Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Hoffmann-La Roche AG Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Johnson & Johnson Immuno-oncology Drugs Basic Information List
Table Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Johnson & Johnson Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Novartis International AG Immuno-oncology Drugs Basic Information List
Table Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure Novartis International AG Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table AbbVie, Inc. Immuno-oncology Drugs Basic Information List
Table AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales (K Units) and Growth Rate (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Sales Market Share in EMEA (2013-2018)
Figure AbbVie, Inc. Immuno-oncology Drugs Revenue Market Share in EMEA (2013-2018)
Table Pfizer Inc. Immuno-oncology Drugs Basic Information List
Table Sanofi S.A. Immuno-oncology Drugs Basic Information List
Table EMD Serono, Inc. Immuno-oncology Drugs Basic Information List
Table Gilead Sciences Inc. Immuno-oncology Drugs Basic Information List
Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Basic Information List
Table Aduro BioTech Immuno-oncology Drugs Basic Information List
Table Galena Biopharma Immuno-oncology Drugs Basic Information List
Table Bavarian Nordic Immuno-oncology Drugs Basic Information List
Table Celldex Therapeutics Immuno-oncology Drugs Basic Information List
Table ImmunoCellular Therapeutics Immuno-oncology Drugs Basic Information List
Table Incyte Immuno-oncology Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-oncology Drugs
Figure Manufacturing Process Analysis of Immuno-oncology Drugs
Figure Immuno-oncology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Immuno-oncology Drugs Major Manufacturers in 2017
Table Major Buyers of Immuno-oncology Drugs
Table Distributors/Traders List
Figure EMEA Immuno-oncology Drugs Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Immuno-oncology Drugs Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Immuno-oncology Drugs Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Immuno-oncology Drugs Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Immuno-oncology Drugs Sales Market Share Forecast by Region (2018-2025)
Table EMEA Immuno-oncology Drugs Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Immuno-oncology Drugs Revenue Market Share Forecast by Region (2018-2025)
Table Europe Immuno-oncology Drugs Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Immuno-oncology Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Europe Immuno-oncology Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Immuno-oncology Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Immuno-oncology Drugs Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Immuno-oncology Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Immuno-oncology Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Immuno-oncology Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Immuno-oncology Drugs Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Immuno-oncology Drugs Sales Market Share Forecast by Countries (2018-2025)
Table Africa Immuno-oncology Drugs Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Immuno-oncology Drugs Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Immuno-oncology Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Immuno-oncology Drugs Sales Market Share Forecast by Type (2018-2025)
Table EMEA Immuno-oncology Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Immuno-oncology Drugs Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *